| Name | Title | Contact Details |
|---|---|---|
Anjana Pursnani |
Senior Vice President and Head of People | Profile |
Kostya Zabrodsky |
Senior Director, Finance/Controller | Profile |
Jay Dietz |
Director, Talent Acquisition Consultant | Profile |
Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases. Our founders` groundbreaking discoveries in RNA interference offer a powerful therapeutic approach to halt diseases at their source.
Annexon is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders of the body, brain and eye. The company`s pipeline is based on its platform technology addressing a broad spectrum of well-researched classical complement-mediated autoimmune and neurodegenerative diseases triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. Annexon is advancing a portfolio of innovative product candidates designed to block the activity of C1q and the entire classical complement pathway: ANX005 (intravenous administration), ANX007 (intravitreal administration) and ANX009 (subcutaneous administration). Annexon is deploying a disciplined, biomarker-driven strategy designed to improve the probability of technical success of its portfolio.
Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health.
RTD Company is a Andover, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Semler Research Center Pvt. is a North Hollywood, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.